Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henri Trau

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Mycoses|June 6, 2009
Onychomycosis in psoriatic patients - rationalization of systemic treatmentAvner Shemer, Henri Trau, Batya Davidovici, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2007
Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nailAvner Shemer, Henri Trau, Batya Davidovici, et al.
The Israel Medical Association Journal : IMAJ|August 2, 2008
Onychomycosis: rationalization of topical treatmentAvner Shemer, Henri Trau, Batya Davidovici, et al.
The Journal of Dermatology|February 24, 2010
Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative studyAvner Shemer, Nir Nathansohn, Henri Trau, et al.
Journal of the American Academy of Dermatology|August 23, 2011
Treatment of erosive oral lichen planus with local ultraviolet B phototherapyRiad Kassem, Noam Yarom, Alon Scope, et al.
Acta Dermato-Venereologica|April 12, 2011
Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticariaLior Sagi, Michal Solomon, Sharon Baum, et al.
Cutis|June 10, 2004
Parry-Romberg syndrome and sympathectomy--a coincidence?Alon Scope, Aviv Barzilai, Henri Trau, et al.
The Journal of Dermatological Treatment|March 26, 2013
Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 casesSharon Baum, Sarit Gilboa, Shoshana Greenberger, et al.
European Journal of Dermatology : EJD|June 15, 2016
Epidemiological data of 290 pemphigus vulgaris patients: a 29-year retrospective studySharon Baum, Nadav Astman, Efraim Berco, et al.
Harefuah|January 16, 2013
[Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders]Alina Lozinski, Sharon Baum, Lior Sagi, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Mycoses|June 6, 2009
Onychomycosis in psoriatic patients - rationalization of systemic treatmentAvner Shemer, Henri Trau, Batya Davidovici, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2007
Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nailAvner Shemer, Henri Trau, Batya Davidovici, et al.
The Israel Medical Association Journal : IMAJ|August 2, 2008
Onychomycosis: rationalization of topical treatmentAvner Shemer, Henri Trau, Batya Davidovici, et al.
The Journal of Dermatology|February 24, 2010
Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative studyAvner Shemer, Nir Nathansohn, Henri Trau, et al.
Journal of the American Academy of Dermatology|August 23, 2011
Treatment of erosive oral lichen planus with local ultraviolet B phototherapyRiad Kassem, Noam Yarom, Alon Scope, et al.
Acta Dermato-Venereologica|April 12, 2011
Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticariaLior Sagi, Michal Solomon, Sharon Baum, et al.
Cutis|June 10, 2004
Parry-Romberg syndrome and sympathectomy--a coincidence?Alon Scope, Aviv Barzilai, Henri Trau, et al.
The Journal of Dermatological Treatment|March 26, 2013
Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 casesSharon Baum, Sarit Gilboa, Shoshana Greenberger, et al.
European Journal of Dermatology : EJD|June 15, 2016
Epidemiological data of 290 pemphigus vulgaris patients: a 29-year retrospective studySharon Baum, Nadav Astman, Efraim Berco, et al.
Harefuah|January 16, 2013
[Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders]Alina Lozinski, Sharon Baum, Lior Sagi, et al.
Pageof 5